Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects

Oseltamivir is the most widely used anti-influenza drug. In the 2009 H1N1 pandemic, in which the influenza viruses were oseltamivir sensitive, obesity was identified as a risk factor for severe disease and unfavorable outcomes. The aim of this study was to investigate the pharmacokinetic properties...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jittamala, Podjanee, Pukrittayakamee, Sasithon, Tarning, Joel, Lindegardh, Niklas, Hanpithakpong, Warunee, Taylor, Walter Robert John, Lawpoolsri, Saranath, Charunwattana, Prakaykaew, Panapipat, Salwaluk, White, Nicholas J., Day, Nicholas P. J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2014
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3957867/
https://ncbi.nlm.nih.gov/pubmed/24366750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01786-13
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak